152 related articles for article (PubMed ID: 34717194)
41. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
42. LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells.
Wu H; Zhong Z; Wang A; Yuan C; Ning K; Hu H; Wang C; Yin X
Cancer Cell Int; 2020; 20():266. PubMed ID: 32595415
[TBL] [Abstract][Full Text] [Related]
43. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
44. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis.
Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S
J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208
[TBL] [Abstract][Full Text] [Related]
45. Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-
Xu L; Yu Y; Sang R; Li J; Ge B; Zhang X
Oxid Med Cell Longev; 2018; 2018():8284107. PubMed ID: 30344887
[TBL] [Abstract][Full Text] [Related]
46. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.
Ding J; Xu M; Du W; Fang ZQ; Xu H; Liu JJ; Song P; Xu C; Li ZW; Yue ZS; Ling YW; Duan JL; Tao KS; He F; Wang L
Int J Biol Sci; 2023; 19(6):1941-1954. PubMed ID: 37063432
[No Abstract] [Full Text] [Related]
47. [Mechanism of catgut embedding at back-
Zhou XL; Tang N; Wu T; Zhang Y; Chen Q; Wei WH; Zhou YN; Zhang DX; Qin FC; Yang W
Zhongguo Zhen Jiu; 2020 Jan; 40(1):59-66. PubMed ID: 31930901
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
49. Oridonin Prolongs the Survival of Mouse Cardiac Allografts by Attenuating the NF-κB/NLRP3 Pathway.
Du X; Que W; Hu X; Yu X; Guo WZ; Zhang S; Li XK
Front Immunol; 2021; 12():719574. PubMed ID: 34566976
[TBL] [Abstract][Full Text] [Related]
50. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization.
Jiang Q; Li Q; Liu B; Li G; Riedemann G; Gaitantzi H; Breitkopf-Heinlein K; Zeng A; Ding H; Xu K
Int Immunopharmacol; 2021 Jul; 96():107591. PubMed ID: 33812253
[TBL] [Abstract][Full Text] [Related]
51. IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells.
Yang F; Wang S; Liu Y; Zhou Y; Shang L; Feng M; Yuan X; Zhu W; Shi X
Free Radic Biol Med; 2018 Aug; 124():395-407. PubMed ID: 29969718
[TBL] [Abstract][Full Text] [Related]
52. Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling.
Wang H; Wang L; Li NL; Li JT; Yu F; Zhao YL; Wang L; Yi J; Wang L; Bian JF; Chen JH; Yuan SF; Wang T; Lv YG; Liu NN; Zhu XS; Ling R; Yun J
Oxid Med Cell Longev; 2014; 2014():851692. PubMed ID: 25147596
[TBL] [Abstract][Full Text] [Related]
53. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
54. Oridonin loaded peptide nanovesicles alleviate nonalcoholic fatty liver disease in mice.
Zhang L; Yu Y; Wang Q; Huang X; Feng Z; Li Z
Pharm Dev Technol; 2024 Feb; 29(2):123-130. PubMed ID: 38327230
[TBL] [Abstract][Full Text] [Related]
55. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525
[TBL] [Abstract][Full Text] [Related]
56. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
57. Herp knockout protects against nonalcoholic fatty liver disease in mice on a high fat diet.
Lei ZX; Wang JJ; Li K; Liu P
Kaohsiung J Med Sci; 2021 Jun; 37(6):487-496. PubMed ID: 33464700
[TBL] [Abstract][Full Text] [Related]
58. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
59. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
60. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways.
Liu L; Guo H; Song A; Huang J; Zhang Y; Jin S; Li S; Zhang L; Yang C; Yang P
BMC Immunol; 2020 Jun; 21(1):32. PubMed ID: 32503416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
